globenewswire news
2026-06-17T16:04:19Z
PRESS RELEASE
2026-06-17T16:00:00Z
MIAMI, June 17, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, Andres...
2026-06-17T15:38:43Z
SCOTTSDALE, Ariz., June 17, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the completion of...
2026-06-17T14:47:04Z
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY...
2026-06-17T13:54:25Z
Lazydaze Coffeeshop - Here We Grow Again
2026-06-17T13:27:00Z
CHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, through its wholly owned...
2026-06-17T13:18:11Z
InvestorsTape.com Closely Watching NTHI Ahead of Multiple Clinical, Regulatory, and Data Catalysts
2026-06-17T13:00:00Z
June 17, 2026
2026-06-17T13:00:00Z
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS17 June 2026 at 16.00 EEST
2026-06-17T13:00:00Z
BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- BPGbio, a clinical-stage biopharmaceutical company advancing mitochondrial-targeted therapeutics for patients, today presents new clinical and translational findings supporting the potential of BPM31510, BPGbio’s investigational...
2026-06-17T13:00:00Z
– On track to also complete enrollment in the Seabreeze STAT COPD study this month –
2026-06-17T12:54:26Z
Both recognitions cite the Layer 7 cortical interface and its potential to restore independence for people living with paralysis
2026-06-17T12:47:00Z
Lead Cell Therapy Demonstrated Complete Tumor Clearance and 100% Long-Term Survival in Preclinical Ovarian Cancer Models; Multiple Regulatory, Manufacturing and Clinical Catalysts Expected Through 2027
2026-06-17T12:45:00Z
Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-R safety data
2026-06-17T12:30:00Z
Company to present at Planet Microcap Conference in Las Vegas between June 16-18
2026-06-17T12:30:00Z
Certification process could position SteraMist® as a validated decontamination standard across biosafety cabinets, containment enclosures, cleanrooms, and life sciences facilities worldwide
2026-06-17T12:15:00Z
Raanana, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced...
2026-06-17T12:00:00Z
Company expects to report topline 12-month clinical results in the second half of 2027
2026-06-17T12:00:00Z
SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB: OTLC) today announced the completion of key Phase 2 objectives in its joint manufacturing...
2026-06-17T12:00:00Z
Five-Year Contract Creates New Opportunities for Distribution Partners Serving VA and Federal Healthcare Facilities
2026-06-17T12:00:00Z
BOSTON, Mass., June 17, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today reported preliminary...
2026-06-17T12:00:00Z
ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess Alpha Virtual...
2026-06-17T11:30:00Z
NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic...
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
2026-06-17T11:30:00Z
- Up to $125 million in additional borrowing capacity provides further strategic flexibility -
2026-06-17T11:30:00Z
LONG BEACH, Calif. and TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that it has...
2026-06-17T11:28:40Z
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging...
2026-06-17T11:12:00Z
A data-driven repricing solution that optimizes cost management and complements existing bill review workflows
2026-06-17T11:05:00Z
~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~
2026-06-17T11:00:00Z
TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. (“Sernova” or the “Company”) (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused on developing...
2026-06-17T11:00:00Z
Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease